{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:53:04Z","timestamp":1762145584554,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K16434"],"award-info":[{"award-number":["17K16434"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clon.2020.07.012","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T08:33:51Z","timestamp":1596530031000},"page":"191-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radiation Dose-escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Oesophageal Squamous Cell Carcinoma: A Single-institution Phase I Study"],"prefix":"10.1016","volume":"33","author":[{"given":"K.","family":"Sakanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2020.07.012_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jjco\/hyh107","article-title":"Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)\/Japan Clinical Oncology Group trial (JCOG9516)","volume":"34","author":"Ishida","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cas.12622","article-title":"Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)","volume":"106","author":"Shinoda","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clon.2020.07.012_bib3","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","article-title":"Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus","volume":"17","author":"Ohtsu","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2010.10.023","article-title":"Esophageal cancer dose escalation using a simultaneous integrated boost technique","volume":"82","author":"Welsh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2020.07.012_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00066-014-0636-y","article-title":"Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study","volume":"190","author":"Yu","year":"2014","journal-title":"Strahlenther Onkol"},{"year":"2009","author":"Sobin","series-title":"TNM classification of malignant tumours","key":"10.1016\/j.clon.2020.07.012_bib7"},{"key":"10.1016\/j.clon.2020.07.012_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10147-016-0967-z","article-title":"Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy","volume":"21","author":"Sakanaka","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib9","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.ijrobp.2011.04.007","article-title":"Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma","volume":"82","author":"Sakanaka","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2020.07.012_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.meddos.2013.01.004","article-title":"Volumetric-modulated arc therapy vs conventional fixed-field intensity-modulated radiotherapy in a whole-ventricular irradiation: a planning comparison study","volume":"38","author":"Sakanaka","year":"2013","journal-title":"Med Dosim"},{"key":"10.1016\/j.clon.2020.07.012_bib11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/jrr\/rrt047","article-title":"Dose-volume analysis for respiratory toxicity in intrathoracic esophageal cancer patients treated with definitive chemoradiotherapy using extended fields","volume":"54","author":"Tanabe","year":"2013","journal-title":"J\u00a0Radiat Res"},{"key":"10.1016\/j.clon.2020.07.012_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2014.12.007","article-title":"Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET\/CT for esophageal cancer","volume":"114","author":"Yu","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jtho.2016.10.013","article-title":"Local control and toxicity of a simultaneous integrated boost for dose escalation in locally advanced esophageal cancer: interim results from a prospective phase I\/II trial","volume":"12","author":"Welsh","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib14","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2020.07.012_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/JCO.2020.38.4_suppl.281","article-title":"A\u00a0randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study","volume":"38","author":"Hulshof","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","article-title":"Staging investigations for oesophageal cancer: a meta-analysis","volume":"98","author":"van Vliet","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2020.07.012_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/jrr\/rrw078","article-title":"Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method","volume":"58","author":"Ito","year":"2017","journal-title":"J\u00a0Radiat Res"},{"key":"10.1016\/j.clon.2020.07.012_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13014-018-0957-6","article-title":"Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma","volume":"13","author":"Sakanaka","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2020.07.012_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jrr\/rrx076","article-title":"Effect of long fasting on myocardial accumulation in 18F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma","volume":"59","author":"Ishida","year":"2018","journal-title":"J\u00a0Radiat Res"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520302946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520302946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:48:53Z","timestamp":1760543333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655520302946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0936655520302946"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2020.07.012","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Dose-escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Oesophageal Squamous Cell Carcinoma: A Single-institution Phase I Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2020.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}